Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 141 - 160 of 444 trials
Titlesort icon Investigator Disease(s)
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-234]
O'Reilly, Eileen
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase IB/IIA Study of ABT-888 in Combination with Bendamustine with or without Rituximab in Patients with Lymphoma, Multiple Myeloma, and Solid Tumors
[Protocol 10-174]
Gerecitano, John
  • Hematology
    • Multiple Myeloma
  • Lymphoma
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
[Protocol 12-170]
Horwitz, Steven
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Low-Risk Prostate Cancer
[Protocol 11-056]
Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
  • Lung Cancer, Small Cell
    • Other
A Phase II Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094]
Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer
[Protocol 12-140]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187]
Scher, Howard
  • Prostate Cancer
    • Rising PSA After Primary Therapy
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer
[Protocol 11-082]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063]
Dickler, Maura
  • Breast Cancer
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of AUY922 in Patients with Myelofibrosis
[Protocol 12-076]
Rampal, Raajit
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
  • Leukemia
    • Myeloproliferative Neoplasm
A Phase II Study of Axitinib in Patients with Recurrent, Progressive/Metastatic Adenoid Cystic Cancer
[Protocol 12-004]
Ho, Alan
  • Head & Neck Cancer
A Phase II Study of Bendamustine and Dexamethasone in Patients with Relapsed Amyloidosis
[Protocol 12-257]
Landau, Heather
  • Hematology
    • Hematologic Malignancies
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015]
Modak, Shakeel
  • Neuroblastoma
A Phase II Study of BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium
[Protocol 11-060]
Bajorin, Dean
  • Bladder Cancer
A Phase II Study of BKM120 in Patients with Metastatic Non-Small Cell Lung Cancer
[Protocol 11-157]
Paik, Paul
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of BKM120 in Patients with Recurrent Glioblastoma and an Activated PI3K Pathway
[Protocol 12-002]
Mellinghoff, Ingo
  • Pediatric Brain Tumors
    • Brain Cancer